Search Results - "Condoluci, Mark"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    523. Dual vs. Triple Antibiotic Therapy for Carbapenem-Resistant Acinetobacter baumannii Infections by Markelwith, Justin Patrick, Vyas, Nikunj M, Condoluci, Mark, Kim, Sungwook

    Published in Open forum infectious diseases (23-10-2019)
    “…Abstract Background Infections caused by carbapenem-resistant Acinetobacter baumannii (CRAB) remain some of the most difficult to treat due to extremely high…”
    Get full text
    Journal Article
  2. 2
  3. 3

    550. Clinical impact of Tocilizumab therapy in SARS-CoV-2 respiratory infections in ICU and non-ICU patients by Vyas, Nikunj M, Hou, Cindy, Levin, Todd P, Fussa, Mark, DeRose, Joseph, Condoluci, Mark, Williams, James, Ghayad, Zeina, Barnish, Michael, Ali, Shereef N, Kerr, Kathryn H, Scheiblein, Scott W, Fryckberg, Anthony J, Chauhan, Gauri

    Published in Open forum infectious diseases (31-12-2020)
    “…Abstract Background Tocilizumab (TCZ) is a monoclonal antibody against the interleuikin-6 receptor which is potentially beneficial in COVID-19 induced cytokine…”
    Get full text
    Journal Article
  4. 4
  5. 5